Search
Johnson & Johnson's Ottava Surgical Robot Receives FDA Marketing Authorization in the United States
9 hour ago /
Read about 0 minute
Author：小编
Johnson & Johnson announced that its soft tissue robotic system, Ottava, has received De Novo authorization from the U.S. FDA for use in soft tissue surgeries such as Roux-en-Y gastric bypass. As the world's first soft tissue robotic system integrated with an operating table, Ottava will be introduced to select customers in the United States at an appropriate time, with plans to expand its applications and seek approvals in more regions.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
